Background/Aims: Circular RNAs (circRNAs) are a family of novel non-coding RNAs associated with various diseases, especially cancer. Recent studies have demonstrated that circRNAs participate in pathogenesis mainly by acting as microRNA (miRNA) sponges. The expression profile of circRNAs in acute myeloid leukemia (AML) has rarely been reported. Methods: Profiles of circRNAs were analyzed using an Arraystar human circRNA microarray with 5 bone marrow samples from patients with newly diagnosed AML and 5 from patients with irondeficiency anemia. Quantitative reverse transcription PCR was used to validate the expression pattern of circRNAs. Furthermore, circRNA-miRNA network, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were applied. Results: CircRNA microarray analysis revealed that 698 circRNAs were differentially expressed in AML patients, with 282 circRNAs found to be upregulated and 416 to be downregulated. Quantitative reverse transcription PCR showed that circ-ANAPC7 was significantly upregulated in AML. Bioinformatics analysis predicted that circ-ANAPC7 acts as a sponge for the miR-181 family, KEGG analysis revealed that it is associated with cancer-related pathways, and GO analysis indicated that most of its target genes are involved in biological processes. Conclusions: These findings show that circ-ANAPC7 is a promising biomarker for AML, and that it might participate in AML pathogenesis by acting as a sponge for the miR-181 family.
Circ-ANAPC7 is Upregulated in

Introduction
Acute myeloid leukemia (AML) is a group of hematopoietic malignancies characterized by a poor prognosis. The pathogenesis of AML is closely associated with various genetic abnormalities that interfere with the growth, proliferation, and differentiation of normal hematopoietic progenitor cells [1, 2] . These abnormalities often lead to rapidly occurring fatal infections, bleeding, or organ infiltration [3] . Overwhelming evidence has established a regulatory role for protein-coding genes in the tumorigenesis, maintenance, and progression of AML, while non-coding RNAs (ncRNAs), such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have also been shown to be of great importance in AML [4] .
CircRNAs are a family of novel ncRNAs that used to be identified as a by-product of abnormal RNA splicing with no biological function. More recently, accumulating evidence has shown that they play a crucial role in post-transcriptional regulation in vivo [5, 6] . CircRNAs are characterized by a covalently closed loop structure lacking 3′ and 5′ ends. They are highly stable and mainly reside in the cytoplasm, and thus have the potential to be used as biomarkers [7] . A number of studies have found that circRNAs, such as CDas1R, have an important function in the pathogenesis of several diseases [5, 8, 9] . However, little is known about the role of circRNAs in human cancer.
CircRNAs have also been observed to act as microRNA (miRNA) sponges, which contribute to the regulation of gene expression. miRNAs are ~23-nt ncRNAs that are implicated in numerous biological processes [10] . For instance, several studies have demonstrated that they function as guide RNAs leading to RNA silencing, and miRNA dysfunction is associated with the development of diseases such as leukemogenesis [11] . miRNAs also participate in post-transcriptional regulation in AML, leading to a cascade of downstream effects and indicating the potential for targeted therapeutic strategies. CircRNA-based therapy is a novel approach to modulate dysregulated miRNAs in AML. Hence, in this study, we investigated the circRNA-miRNA regulatory network in AML.
We first explored the expression profile of circRNAs in 5 AML samples and 5 irondeficiency anemia (IDA) samples (control group) that were collected from the bone marrow of patients. Then, we validated one circRNA (hsa_circRNA_101141) derived from the ANAPC7 gene locus, termed circANAPC7, which was frequently upregulated in patients with AML. Finally, we found that circANAPC7 may act as a miR-181 sponge by bioinformatics analysis.
Materials and Methods
Patients and specimen collection
This study involved 87 patients diagnosed with AML and 45 patients diagnosed with IDA as a control group. All individuals were of Han Chinese ethnicity and were recruited from the Second Affiliated Hospital of Xi'an Jiaotong University. None of the patients had previously undergone chemotherapy. All specimens were obtained from bone marrow aspiration, and after removal were immediately preserved at −80°C until required. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Xi'an Jiaotong University (No. 2015181) and met international standards for patient confidentiality. Written informed consent was obtained from all patients.
Total RNA extraction Total tissue RNA was extracted from the AML and IDA samples using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The purity and concentration of RNA samples were determined with a NanoDrop ND-1000 (Thermo Fisher Scientific, Wilmington, DE, USA).
Microarray analysis
We selected five AML specimens and five IDA specimens for microarray analysis. Total RNA was treated with RNase R to enrich circular RNAs. The enriched circular RNAs were then amplified and transcribed into fluorescent cRNA utilizing random primers according to the Arraystar Super RNA Labeling protocol CircRNA microarray data analysis Data were extracted using Agilent Feature Extraction software. Data processing, including quantile normalization, was performed using R software. CircRNAs that were significantly differentially expressed between the AML and IDA groups were identified using a fold-change cut-off value or through volcano plot filtering. The prediction of miRNA targets for circRNAs and circRNA-miRNA interactions was conducted using the TargetScan and miRanda algorithms.
Validation of candidate circRNAs using quantitative reverse transcription polymerase chain reaction
Candidate circRNAs were selected for validation if they met the following criteria: 1) the raw intensity of all tested samples was greater than 500; 2) the P-value of the circRNAs between AML and IDA was <0.01; 3) the fold change in expression between AML and IDA was >2.5; and 4) the miRNAs in the predicted circRNA-miRNA-mRNA/lncRNA network has been proven to be associated with AML in previous studies. cDNA was synthesized by reverse transcription using a PrimeScript RT Master Mix with random primers according to manufacturer's protocols (TaKaRa Bio, Shiga, Japan). Then, quantitative reverse transcription PCR (qRT-PCR) was performed using SYBR Premix Ex Taq TM II (Tli RNaseH Plus) (TaKaRa) following the manufacturer's instructions. Divergent primers were synthesized by Invitrogen (Shanghai, China) and the sequences are shown in Table 1 .
CircRNA-microRNA co-expression network
Validated candidate circRNAs were used as seeds to enrich a circRNA-miRNA-mRNA/lncRNA network according to the analysis of starBase v2.0 (http://starbase.sysu.edu.cn/) [12] . Cytoscape (http://www.cytoscape.org/) was applied to build a circRNA-miRNA-mRNA/lncRNA network. miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/) was used to extract experimentally validated targets of the top 5 predicted miRNAs for validated candidate circRNAs [13] .
Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses
Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were carried out using the DAVID analysis tool (https://david.ncifcrf.gov/) to define further the biological pathways of the predicted miRNAs. Gene Ontology (GO) analysis was also performed to clarify the functional roles of miRNA target genes.
Statistical analysis
Results are reported as means ± standard deviation for triplicate measurements. Significant differences between groups were estimated by the Mann-Whitney test using SPSS v.23.0 software (IBM, Chicago, IL, USA). P < 0.05 was considered statistically significant.
Results
Profiling of differentially expressed circRNAs in AML patients
The expression of 7441 human circRNAs was quantitated for the AML and IDA samples using a microarray platform. Hierarchical clustering and scatter plot visualization showed that circRNA expression levels were variable and distinguishable among the samples (Fig.  1) . 
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A total of 698 circRNAs were differentially expressed (fold change ≥ 2.0, P < 0.05) between the AML and IDA samples, with 282 circRNAs found to be upregulated and 416 to be downregulated by more than 2-fold in AML patients compared with IDA patients. Analysis of the chromosomal distribution of circRNAs revealed that chromosome 1 had the greatest number of differentially expressed circRNAs, while mitochondrial DNA and chromosome 13 had the lowest number of differentially expressed circRNAs (Fig. 2a) . The classification of all differentially expressed circRNAs is shown in Fig. 2b . Most differentially expressed circRNAs are transcribed from protein-coding exons, some are derived from introns, while a small number come from other sources. These data suggest that the expression of circRNAs in the bone marrow of AML patients differs from that in IDA patients. Cell 
Fig. 4.
CircRNA-miRNA-mRNA/lncRNA coexpression network. The red, yellow, purple, and blue nodes represent circRNA, miRNA, mRNA, and lncRNA, respectively. 
Validation of differentially expressed circRNAs by qRT-PCR
Considering the lower expression level of circRNAs and difficultly in overexpression functional test techniques, we selected only upregulated circRNAs for further validation according the criteria described in the Materials and Methods. Finally, circ-ANAPC7 (hsa_circRNA_101141) and circ-PI4KA (hsa_circRNA_103164) were tested by qRT-PCR in 87 AML and 45 IDA bone marrow samples. As shown in Fig. 3 , circ-ANAPC7 was significantly upregulated in AML patients, while circ-PI4KA showed a trend toward overexpression in AML patients, but this was not significant (data not shown). There was no significant difference in age and sex between the AML and IDA groups (data not shown).
miRNA prediction and bioinformatics analyses
Bioinformatics analysis showed that circ-ANAPC7 harbored miRNA response elements (MREs) for hsa-miR-181a-5p, hsa-miR-181b-5p, hsa-miR-181d-5p, hsa-miR-338-3p, and hsa-miR-526b-5p (Fig. 4) . This was confirmed by the starBase database for hsa-miR-181a-5p, hsa-miR-181b-5p, and hsa-miR-181d-5p MREs, suggesting that circ-ANAPC7 might regulate miRNA-associated target genes in AML by acting as a sponge for the miR-181 family. To clarify the biological function of these five miRNAs, we extracted their validated targets from miRTarBase. miR-181a was shown to Fig. 6 . KEGG pathway analysis. Figure 6 . KEGG pathway analysis. RGS5 RALA PRKCD ATM TERT DDIT4 HIPK2 SIRT1   ATG5 BCL2 WIF1 RAP1B E2F5 NLK GATA6 CDX2   BCL2L11 PRAP1 FOS MTMR3 MCL1 XIAP GPR78   PPP3CA TWIST1 RNF2 MAP2K1 ABCG2 MAPK1   ZNF763 PROX1 KLF6 DDX3X KRAS PBX3 TIMP1   PGR COL16A1 TGFBRAP1 TGFBR1 HRAS DUSP6   PTPN11 DUSP5 PTPN22 NOTCH1 CDKN1B IFNG   KAT2B PLAG1   RGS5 RALA PRKCD ATM CD4 BCL2 WIF1 RAP1B   E2F5 RNF2 MAP2K1 ABCG2 MAPK1 ZNF763   PROX1 BCL2L11 KLF6 DDX3X KRAS PBX3   TIMP1 PGR COL16A1 TGFBRAP1 TGFBR1 HRAS   DUSP6 PTPN11 DUSP5 PTPN22 NOTCH1   CDKN1B IFNG AHR STAT3 KAT2B PLAG1   RGS5 RALA PRKCD ATM CD4 TERT DDIT4 HIPK2   SIRT1 ATG5 BCL2 WIF1 RAP1B E2F5 RNF2 MAP2K1   ABCG2 MAPK1 PROX1 BCL2L11 KLF6 DDX3X KRAS   PBX3 TIMP1 PGR COL16A1 TGFBRAP1 TGFBR1 HRAS   CDKN1B C12ORF29 PHACTR2 SASH1 PHLDA1   MOSPD1 SRGAP1 UBL3 PHACTR4 EREG IFNG AHR   STAT3   RGS5 RALA PRKCD ATM TERT DDIT4 HIPK2 SIRT1 ATG5 BCL2 WIF1   RAP1B E2F5 NLK GATA6 CDX2 BCL2L11 PRAP1 FOS MTMR3 MCL1   XIAP GPR78 PPP3CA TWIST1 RNF2 MAP2K1 ABCG2 MAPK1 ZNF763   PROX1 KLF6 DDX3X KRAS PBX3 TIMP1 PGR COL16A1 TGFBRAP1   TGFBR1 HRAS DUSP6 PTPN11 DUSP5 PTPN22 NOTCH1 hsa-miR-526b-5p none none none none have the most targets, while miR-526 had none. The details of the validated targets of the five miRNAs are shown in Table 2 .
To investigate further the molecular mechanism of circRNAs, the circ-ANAPC7-miRNA-mRNA/lncRNA network was constructed by Cytoscape (Fig. 5) . Moreover, because these miRNAs have been suggested to play important roles in oncogenesis, KEGG pathway enrichment analysis was conducted using DAVID (Fig. 6) . The five miRNAs appeared to be strongly associated with cancer-related pathways (Fig. 7) . Table 3 lists the combinatorial effect of the five miRNAs in the top 20 pathways and their target genes. GO enrichment analysis of circ-ANAPC7 target genes revealed that their properties could be defined as molecular function and cellular component (data not shown). These processes are closely associated with AML tumorigenesis.
Discussion
AML is a heterogeneous clonal malignancy characterized by the failure of hematopoietic proliferation [14] . Within China, the incidence of leukemia is approximately 4.44 per 100, 000 men and 3.09 per 100, 000 women [15] . Despite rapid advances in AML therapy, including the development of novel drug targets and transplantation, treatment has remained stagnant for the past few decades, with most patients relapsing and dying of complications [16] . Even with current treatment, the majority of patients older than 65 years will die of AML within 1 year [17, 18] . To address this issue, research has focused on the identification of novel targets for AML therapy.
A wide range of evidence has indicated that ncRNAs such as circRNAs play an important role in leukemogenesis [19] [20] [21] ; thus, circRNA-based therapy is a feasible approach for the treatment of AML. Aberrant circRNA expression has been associated with the malignant 
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Cellular Physiology and Biochemistry behavior of cancers [22, 23] , but few studies have reported the potential roles of circRNAs in AML.
Here, we explored differences in the expression patterns of circRNAs between AML and IDA patients. Microarray analysis identified 282 circRNAs that were upregulated and 416 that were downregulated in AML, suggesting their potential involvement in disease pathogenesis. We further demonstrated by qRT-PCR that circ-ANAPC7 was significantly upregulated in AML, indicating that it could act as an oncogenic circRNA. Bioinformatics analysis predicted that circ-ANAPC7 functioned as a sponge for the miR-181 family because it harbored several MREs for this family. These results are consistent with our previous hypothesis that circRNAs are oncogenic in AML, and suggest that circ-ANAPC7 could be used as a biomarker for AML diagnosis or as a novel drug target.
The miR-181 family comprises miR-181a, miR-181b, miR-181c, and miR-181d, which are encoded by three different transcripts located on three chromosomes. All miR-181 family members contain similar seed sequences that differ by fewer than four nucleotides [24] . Previous studies have demonstrated that the miR-181 family regulates the differentiation of B cells, T cells, and natural killer cells during normal hematopoiesis [25] [26] [27] . miR-181a was reported to regulate non-small cell lung cancer proliferation and migration through targeting VCAM-1 [28] . In some tumors, the miR-181 family was shown to target the antiapoptotic genes BCL2 and MCL1, leading to apoptosis and the inhibition of tumor growth. Dysregulation of the miR-181 family was also shown to be closely associated with the pathogenesis and prognosis of AML. Additionally, members of the miR-181 family were demonstrated to mediate several cancer-related pathways, such as the RAS/MAPK pathway, thus acting as tumor suppressors in myeloid leukemogenesis [29, 30] . Therefore, targeting the circ-ANAPC7-miR-181 axis may be a novel therapeutic approach for AML.
This study has a number of limitations. First, we chose IDA patients as our control group because it is difficult to obtain bone marrow samples from healthy individuals. Second, we validated circ-ANAPC7 as a competitive endogenous RNA of the miR-181 family by only bioinformatics analysis, and not by experimental means. Finally, we did not elucidate the clinical significance of circ-ANAPC7 because of the short follow-up period. Further studies are therefore needed to determine the clinical significance and underlying mechanisms of circ-ANAPC7 in the pathogenesis of AML.
Conclusion
This study shows that circ-ANAPC7 is a promising biomarker for AML, and that it might participate in the pathogenesis of AML by acting as a sponge for the miR-181 family.
Abbreviations miR (or miRNA; microRNA); circRNA; circular (RNA); ncRNA; non-coding (RNA); AML (acute myeloid leukemia); IDA; iron-deficiency (anemia); lncRNA; long (non-coding RNA); qRT-PCR; quantitative (reverse transcription PCR); GO; Gene (Ontology); KEGG; Kyoto (Encyclopedia of Genes and Genomes); MRE; miRNA (response element).
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